FDA Approved: AZITHROMYCIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for AZITHROMYCIN from Lupin Pharmaceuticals, Inc., signaling an update to the product's regulatory approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis
• Chlamydia Infection
• Community-acquired Pneumonia
• Gonorrhea
• Otitis Media
• Pelvic Inflammatory Disease
• Pharyngitis
• Tonsillitis

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

SUPPL AP for AZITHROMYCIN (AZITHROMYCIN)